Application of Age, Body Mass Index, Chronic Kidney Disease, Diabetes, and Genotyping Score for Efficacy of Clopidogrel: Secondary Analysis of the CHANCE Trial - Dai, Liye; Xu, Jie; Yan, Hongyi; Chen, Zimo; Pan, Yuesong; Meng, Xia; Li, Hao; Wang, Yongjun (Stroke (1970), 2022)
Keywords: Age Factors; Aged; Aspirin - therapeutic use; Body Mass Index; Cerebrovascular Disorders - drug therapy; Cerebrovascular Disorders - genetics; Clopidogrel - therapeutic use; Cytochrome P-450 CYP2C19 - genetics; Diabetes Mellitus; Drug Therapy, Combination; Female; Genotype; Humans; Ischemic Attack, Transient - drug therapy; Male; Middle Aged; Platelet Aggregation Inhibitors - therapeutic use; Recurrence; Renal Insufficiency, Chronic - complications; Stroke - drug therapy; Treatment Outcome; clopidogrel; risk factors; stroke; genotype